Mason Street Advisors’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-38,989
| Closed | -$1.02M | – | 283 |
|
|
2020
Q4 | $1.02M | Sell |
38,989
-30
| -0.1% | -$785 | 0.02% | 921 |
|
|
2020
Q3 | $679K | Buy |
39,019
+297
| +0.8% | +$5.17K | 0.01% | 986 |
|
|
2020
Q2 | $651K | Buy |
38,722
+2,898
| +8% | +$48.7K | 0.01% | 984 |
|
|
2020
Q1 | $426K | Hold |
35,824
| – | – | 0.01% | 1045 |
|
|
2019
Q4 | $433K | Buy |
35,824
+1,081
| +3% | +$13.1K | 0.01% | 1181 |
|
|
2019
Q3 | $491K | Sell |
34,743
-146
| -0.4% | -$2.06K | 0.01% | 1107 |
|
|
2019
Q2 | $389K | Buy |
34,889
+1,361
| +4% | +$15.2K | 0.01% | 1176 |
|
|
2019
Q1 | $394K | Buy |
33,528
+895
| +3% | +$10.5K | 0.01% | 1209 |
|
|
2018
Q4 | $436K | Buy |
32,633
+1,341
| +4% | +$17.9K | 0.01% | 1080 |
|
|
2018
Q3 | $439K | Buy |
31,292
+3,672
| +13% | +$51.5K | 0.01% | 1151 |
|
|
2018
Q2 | $434K | Buy |
27,620
+1,180
| +4% | +$18.5K | 0.01% | 1127 |
|
|
2018
Q1 | $435K | Buy |
26,440
+4,661
| +21% | +$76.7K | 0.01% | 1087 |
|
|
2017
Q4 | $393K | Buy |
+21,779
| New | +$393K | 0.01% | 1111 |
|